• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA在胆管癌中的新兴作用及其临床意义

The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.

作者信息

Ferreira Martins Nina Nayara, da Silva Oliveira Kelly Cristina, Braga Bona Amanda, de Arruda Cardoso Smith Marília, Ishak Geraldo, Assumpção Paulo Pimentel, Burbano Rommel Rodríguez, Calcagno Danielle Queiroz

机构信息

Núcleo de Pesquisas em Oncologia, Universidade Federal do Pará, Belém, PA, Brazil.

Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, PA, Brazil.

出版信息

Gastroenterol Res Pract. 2016;2016:9797410. doi: 10.1155/2016/9797410. Epub 2016 Dec 27.

DOI:10.1155/2016/9797410
PMID:28115929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5223017/
Abstract

Biliary tract cancers are aggressive malignancies that include gallbladder cancer and tumors of intra- and extrahepatic ducts and have a poor prognosis. Surgical resection remains the main curative therapy. Nevertheless, numerous patients experience recurrence even after radical surgery. This scenario drives the research to identify biliary tract cancer biomarkers despite the limited progress that has been made. Recently, a large number of studies have demonstrated that deregulated expression of microRNAs is closely associated with cancer development and progression. In this review, we highlight the role and importance of microRNAs in biliary tract cancers with an emphasis on utilizing circulating microRNAs as potential biomarkers. Additionally, we report several single-nucleotide polymorphisms in genes that are associated with the susceptibility of biliary tract tumors.

摘要

胆道癌是侵袭性恶性肿瘤,包括胆囊癌以及肝内和肝外胆管肿瘤,预后较差。手术切除仍然是主要的治愈性疗法。然而,许多患者即使在根治性手术后仍会复发。这种情况推动了对胆道癌生物标志物的研究,尽管进展有限。最近,大量研究表明,微小RNA的表达失调与癌症的发生和发展密切相关。在本综述中,我们重点介绍了微小RNA在胆道癌中的作用和重要性,强调将循环微小RNA作为潜在生物标志物的应用。此外,我们报告了与胆道肿瘤易感性相关基因中的几个单核苷酸多态性。

相似文献

1
The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.微小RNA在胆管癌中的新兴作用及其临床意义
Gastroenterol Res Pract. 2016;2016:9797410. doi: 10.1155/2016/9797410. Epub 2016 Dec 27.
2
Genetic alteration regulated by microRNAs in biliary tract cancers.微小RNA调控的胆管癌基因改变
Crit Rev Oncol Hematol. 2015 Nov;96(2):262-73. doi: 10.1016/j.critrevonc.2015.05.015. Epub 2015 Jun 4.
3
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.循环微小RNA作为胆道癌的生物标志物
Int J Mol Sci. 2016 May 23;17(5):791. doi: 10.3390/ijms17050791.
4
MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers.微小RNA 141的表达是胆道癌潜在的预后标志物。
Gut Liver. 2016 Sep 15;10(5):836-41. doi: 10.5009/gnl15460.
5
Surgical management of biliary tract cancers.胆道癌的外科治疗
Chin Clin Oncol. 2016 Oct;5(5):63. doi: 10.21037/cco.2016.10.03.
6
MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.用于诊断胰腺癌和胆管癌的微小RNA标志物。
PLoS One. 2015 Feb 23;10(2):e0118220. doi: 10.1371/journal.pone.0118220. eCollection 2015.
7
Non-coding RNAs as emerging molecular targets of gallbladder cancer.非编码RNA作为胆囊癌新出现的分子靶点
Gene. 2016 Aug 15;588(1):79-85. doi: 10.1016/j.gene.2016.04.047. Epub 2016 Apr 27.
8
Expression of anterior gradient 2 is decreased with the progression of human biliary tract cancer.随着人类胆道癌的进展,前梯度2的表达降低。
Tohoku J Exp Med. 2014 Sep;234(1):83-8. doi: 10.1620/tjem.234.83.
9
Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.通过人胆管癌中O(6)-甲基鸟嘌呤-DNA甲基转移酶的表观遗传基因沉默实现肿瘤进展。
Ann Surg Oncol. 2005 May;12(5):354-63. doi: 10.1245/ASO.2005.07.020. Epub 2005 Mar 31.
10
[Management of biliary tract carcinomas].[胆管癌的管理]
Rev Prat. 2009 Apr 20;59(4):469-73.

引用本文的文献

1
Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases.胆胰疾病患者血浆中肿瘤抑制性微小RNA的甲基化
Cancer Diagn Progn. 2022 May 3;2(3):378-383. doi: 10.21873/cdp.10120. eCollection 2022 May-Jun.
2
Liquid biopsy provides new insights into gastric cancer.液体活检为胃癌提供了新的见解。
Oncotarget. 2018 Feb 21;9(19):15144-15156. doi: 10.18632/oncotarget.24540. eCollection 2018 Mar 13.

本文引用的文献

1
Identification of a circulating microRNA signature to distinguish recurrence in breast cancer patients.用于区分乳腺癌患者复发情况的循环微小RNA特征的鉴定。
Oncotarget. 2016 Aug 23;7(34):55231-55248. doi: 10.18632/oncotarget.10485.
2
The role of microRNAs in gallbladder cancer.微小RNA在胆囊癌中的作用。
Mol Clin Oncol. 2016 Jul;5(1):7-13. doi: 10.3892/mco.2016.905. Epub 2016 May 11.
3
Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing.使用靶向测序技术分析胆管癌的基因组改变
Transl Oncol. 2016 Jun;9(3):173-8. doi: 10.1016/j.tranon.2016.01.007. Epub 2016 Apr 22.
4
Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.循环微小RNA作为胆道癌的生物标志物
Int J Mol Sci. 2016 May 23;17(5):791. doi: 10.3390/ijms17050791.
5
miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.靶向ZFX的miR-101通过调节胆囊癌中的MAPK/Erk和Smad信号通路抑制肿瘤增殖和转移。
Oncotarget. 2016 Apr 19;7(16):22339-54. doi: 10.18632/oncotarget.7970.
6
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.血清微小RNA作为原发性硬化性胆管炎和胆管癌的新型生物标志物。
Clin Exp Immunol. 2016 Jul;185(1):61-71. doi: 10.1111/cei.12776. Epub 2016 May 17.
7
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.微小RNA与个性化医疗:评估其作为癌症生物标志物的潜力
Adv Exp Med Biol. 2015;888:5-15. doi: 10.1007/978-3-319-22671-2_2.
8
Diagnostic Relevance of microRNAs in Other Body Fluids Including Urine, Feces, and Saliva.微小RNA在包括尿液、粪便和唾液在内的其他体液中的诊断相关性
Exp Suppl. 2015;106:245-252. doi: 10.1007/978-3-0348-0955-9_11.
9
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.循环中的miR-106a是胆管癌的一种新型预后及淋巴结转移指标。
Sci Rep. 2015 Nov 4;5:16103. doi: 10.1038/srep16103.
10
MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.原发性硬化性胆管炎和/或胆管癌患者血清和胆汁中的微小RNA
PLoS One. 2015 Oct 2;10(10):e0139305. doi: 10.1371/journal.pone.0139305. eCollection 2015.